$12.47
0.11[0.89%]
At close: Apr 29
$12.47
0[0.00%]
After Hours: 4:00PM EDT
Nurix Therapeutics: Insider buying and selling updated today.
Filing Date | Insider Names | Insider Title | Qty. | Price | Size ($) | Type | Δ Own | Own | Trade Dates | SEC Filing |
---|---|---|---|---|---|---|---|---|---|---|
Feb 16, 2024 | Hans van Houte | CHIEF FINANCIAL OFFICER | -6.812K | $10.02 | -$68.22K | SELL | -9.07% | 68.333K | Feb 16 | View |
Jan 30, 2024 | Hans van Houte | CHIEF FINANCIAL OFFICER | 3.215K | $7.99 | -$13.35K | SELL-OPTIONS | 4.47% | 75.145K | Jan 30 | View |
Jan 30, 2024 | Gwenn Hansen | CHIEF SCIENTIFIC OFFICER | 2.873K | $7.99 | -$18.65K | SELL-OPTIONS | 8.57% | 36.402K | Jan 30 | View |
Jan 30, 2024 | Christine Ring | CHIEF LEGAL OFFICER | 2.164K | $7.99 | -$14.06K | SELL-OPTIONS | 14.18% | 17.427K | Jan 30 | View |
Dec 21, 2023 | Hans van Houte | CHIEF FINANCIAL OFFICER | -3.541K | $10.00 | -$35.42K | SELL | -4.69% | 71.93K | Dec 20 | View |
Dec 20, 2023 | Hans van Houte | CHIEF FINANCIAL OFFICER | -10.906K | $10.00 | -$109.09K | SELL | -12.63% | 75.471K | Dec 19 | View |
Nov 01, 2023 | Hans van Houte | CHIEF FINANCIAL OFFICER | 3.806K | $5.20 | -$5.61K | SELL-OPTIONS | 4.61% | 86.377K | Oct 30 - Oct 31 | View |
Nov 01, 2023 | Christine Ring | CHIEF LEGAL OFFICER | 2.692K | $5.20 | -$6.40K | SELL-OPTIONS | 21.41% | 15.263K | Oct 30 - Oct 31 | View |
Nov 01, 2023 | Gwenn Hansen | CHIEF SCIENTIFIC OFFICER | 3.574K | $5.20 | -$8.49K | SELL-OPTIONS | 11.93% | 33.529K | Oct 30 - Oct 31 | View |
Aug 01, 2023 | Hans van Houte | CHIEF FINANCIAL OFFICER | 3.641K | $9.65 | -$12.02K | SELL-OPTIONS | 4.61% | 82.571K | Jul 30 - Jul 31 | View |
Aug 01, 2023 | Christine Ring | GENERAL COUNSEL | 2.504K | $9.65 | -$13.71K | SELL-OPTIONS | 24.94% | 12.544K | Jul 30 - Jul 31 | View |
Aug 01, 2023 | Gwenn Hansen | CHIEF SCIENTIFIC OFFICER | 3.323K | $9.65 | -$18.19K | SELL-OPTIONS | 12.48% | 29.955K | Jul 30 - Jul 31 | View |
May 02, 2023 | Stefani Wolff | EVP AND COO | 620 | $9.88 | -$3.38K | SELL-OPTIONS | 11.29% | 6.113K | Apr 30 - May 01 | View |
May 02, 2023 | Hans van Houte | CHIEF FINANCIAL OFFICER | 2.165K | $9.88 | -$7.12K | SELL-OPTIONS | 2.82% | 78.93K | Apr 30 - May 01 | View |
May 02, 2023 | Christine Ring | GENERAL COUNSEL | 1.242K | $9.88 | -$6.74K | SELL-OPTIONS | 14.12% | 10.04K | Apr 30 - May 01 | View |
May 02, 2023 | Gwenn Hansen | CHIEF SCIENTIFIC OFFICER | 2.07K | $9.88 | -$11.22K | SELL-OPTIONS | 8.43% | 26.632K | Apr 30 - May 01 | View |
Feb 01, 2023 | Stefani Wolff | EVP AND COO | 538 | $11.78 | -$4.99K | SELL-OPTIONS | 15.81% | 3.94K | Jan 30 | View |
Feb 01, 2023 | Hans van Houte | CHIEF FINANCIAL OFFICER | 1.962K | $11.78 | -$10.88K | SELL-OPTIONS | 2.62% | 76.765K | Jan 30 | View |
Feb 01, 2023 | Christine Ring | GENERAL COUNSEL | 1.076K | $11.78 | -$9.99K | SELL-OPTIONS | 17.40% | 7.261K | Jan 30 | View |
Browse insider trades on all stocks.